What amount sold does Nexus Ventures VII Trovota LLC report in Form D filings?

The latest linked filings report $525K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Nexus Ventures VII Trovota LLC's most recent SEC filing?

Nexus Ventures VII Trovota LLC's most recent Form D filing was on 2022-08-17.

How many investors does Nexus Ventures VII Trovota LLC have?

The most recent Form D filing lists 8 investor(s).

What type of securities does Nexus Ventures VII Trovota LLC offer?

Nexus Ventures VII Trovota LLC's SEC Form D filings indicate equity offerings.

Nexus Ventures VII Trovota LLC

CIK: 0001941697·Other Technology·MATTHEWS, NC·Limited Liability Company·Founded 2022

Reported Sold

$525,000

Total Filings

Identified Offerings

Last Filed

Aug 17, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Technology industry

SEC EDGAR

Offering filing timeline

Aug 17, 2022Form D — New notice

Reported sold: $525,000 · Target: $525,000

Rule 506(b)·8 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$525,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Nadir Noorani

Related Person

Appears on 1 filing

Anup Desai

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 17, 2022	New	$525,000	$525,000	8

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

ClinTrial Research, Inc.

Other Technology

Offering target: $500,000

Filed Oct 27, 2026